Lisa Graver, CEO
Lisa joined Alvogen in 2010 and serves as the CEO of Alvogen’s business. She has worked in various leadership roles in the pharmaceutical industry for the past 20 years. Her background in patent and regulatory strategy has been a key ingredient in Alvogen’s success.
Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market. The executive leadership team forms the Alvogen Management Board.
Chief Legal Officer
SVP US Research & Development
VP – US Regulatory Affairs
VP - US Information Technology
Sr. VP – US Supply Chain
Sr Director - US Human Resources
VP - US Sales & Marketing Generics
VP - US commercialization - Injectables